A Comparative Study of Acinetobacter Infections in COVID and Non-COVID Patients

Abstract

Acinetobacter species are associated with high mortality, with A. baumannii being associated with a significant number of hospitals acquired infections worldwide. Multidrug resistance makes it challenging to control or treat these infections. Aim of this study is to evaluate the risk factors and compare the clinical outcomes of Acinetobacter infections in a tertiary care hospital, in COVID and non COVID patients.